Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,963.00
Bid: 1,963.00
Ask: 1,600.00
Change: -37.00 (-1.85%)
Spread: -363.00 (-18.492%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Equities Firm Ahead Of Central Bank Meetings

Thu, 05th Sep 2013 09:56

LONDON (Alliance News) - London's main equity markets all trade modestly higher by mid morning Thursday with the FTSE 100 up just 0.2% at 6,488 points. The FTSE 250 is 0.5% higher, while the AIM All-Share is 0.1% higher.

European markets opened with positivity taken from Asia, where markets have closed higher after the Bank of Japan revised up its assessment of the economy but kept liquidity high, with its monetary easing program unchanged. The FTSE 100, CAC 40 and DAX all opened strongly, each rising about 0.5% but have slid slightly by mid morning with the European majors now about flat on the day.

Traders seem less concerned this morning by the ongoing debate over military intervention in Syria over its alleged use of chemical weapons. US President Barack Obama secured backing from a Senate committee late on Wednesday for a limited strike on the country, but will now have to get through a full House and Senate vote which will wait until next week.

Following Wednesday's profit warning from Ryanair that sent all airline stocks tumbling, most are rebounding strongly Thursday after the release of August traffic statistics from easyJet that showed an increase in passenger numbers of 3.9% over the month. EasyJet shares trade 1.56% higher, and International Consolidated Airlines Group trade 2% higher.

At the other end of the spectrum, pharmaceuticals are amongst the biggest fallers as GSK released disappointing results of tests of a new melanoma treatment drug. GSK is one of the biggest blue-chip fallers, down 1.5%. Hikma is down 0.9% and Shire down 0.3%.

Another positive economic reading for the UK has come in the form of new car sales, which have increased for the 18th month in a row and are now above pre-recession levels. The data is helping the pound to maintain Wednesday's break above 1.56 against the dollar, currently trading at USD1.5615.

Big events still to come are central bank meetings.

The BoE's decisions on interest rates and asset purchasing are due at mid-day. No change is expected, and there is no mandatory statement. With every economic indicator of late coming out strongly, Governor Mark Carney may prefer to remain quiet Thursday. However if any statement is released it will be watched with keen interest as to how Carney will further defend his forward guidance.

Also, at 1245 BST, the ECB will announce interest rates. Again, no change expected but Governor Mario Draghi will be giving his usual press conference.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.